Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized cohort study of standardized reduction of subcutaneous immunoglobulin in CIDP
2017-002024-24Phase 4Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of subcuvia in chronic inflammatory demyelinating polyneuropathy (CIDP) (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Change in overall disability sum score (ODSS). Started Jun 2017; status: completed.
02
Drugs
subcuvia
03
Conditions
chronic inflammatory demyelinating polyneuropathy (CIDP)
Beyond the preview
Go deeper on 2017-002024-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002024-24.